Cargando…
Strategies for Pharmacological Organoprotection during Extracorporeal Circulation Targeting Ischemia-Reperfusion Injury
Surgical correction of congenital cardiac malformations or aortocoronary bypass surgery in many cases implies the use of cardiopulmonary-bypass (CPB). However, a possible negative impact of CPB on internal organs such as brain, kidney, lung and liver cannot be neglected. In general, CPB initiates a...
Autores principales: | Salameh, Aida, Dhein, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686733/ https://www.ncbi.nlm.nih.gov/pubmed/26733868 http://dx.doi.org/10.3389/fphar.2015.00296 |
Ejemplares similares
-
Mind the gap! Connexins and pannexins in physiology, pharmacology and disease
por: Salameh, Aida, et al.
Publicado: (2013) -
Epigallocatechin Gallate Reduces Ischemia/Reperfusion Injury in Isolated Perfused Rabbit Hearts
por: Salameh, Aida, et al.
Publicado: (2018) -
Olesoxime Inhibits Cardioplegia-Induced Ischemia/Reperfusion Injury. A Study in Langendorff-Perfused Rabbit Hearts
por: Salameh, Aida, et al.
Publicado: (2017) -
Anti-oxidative or anti-inflammatory additives reduce ischemia/reperfusions injury in an animal model of cardiopulmonary bypass
por: Salameh, Aida, et al.
Publicado: (2020) -
Role of curcumin in ischemia and reperfusion injury
por: Bi, Minglei, et al.
Publicado: (2023)